MedPath
TGA Approval

VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe (363251)

363251

VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe

Maxx Pharma Pty Ltd

March 23, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ca5b42c0d438ea102e6f4be0737b4df2.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/b613b0a96a578ca413ba852d712b42b9.pdf

Active Ingredients

Diphtheria toxoid

hepatitis B surface antigen

Haemophilus influenza type B polyribose ribitol phosphate

Pertactin

Pertussis filamentous haemagglutinin

Pertussis fimbriae 2 + 3

Pertussis toxoid

Tetanus toxoid

Poliovirus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VAXELIS DTPa5-HepB-IPV-Hib vaccine suspension for injection in 0.5 mL pre-filled syringe (363251) - TGA 批准文号 | MedPath